Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Non-Current Debt (2016 - 2024)

Prestige Consumer Healthcare has reported Non-Current Debt over the past 14 years, most recently at $1.1 billion for Q1 2024.

  • Quarterly results put Non-Current Debt at $1.1 billion for Q1 2024, down 16.35% from a year ago — trailing twelve months through Mar 2024 was $1.1 billion (down 16.35% YoY), and the annual figure for FY2024 was $1.1 billion, down 16.35%.
  • Non-Current Debt for Q1 2024 was $1.1 billion at Prestige Consumer Healthcare, down from $1.3 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for PBH hit a ceiling of $1.7 billion in Q1 2020 and a floor of $1.1 billion in Q1 2024.
  • Median Non-Current Debt over the past 5 years was $1.5 billion (2021), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Non-Current Debt: dropped 0.2% in 2022 and later fell 16.35% in 2024.
  • Prestige Consumer Healthcare's Non-Current Debt stood at $1.5 billion in 2020, then decreased by 0.22% to $1.5 billion in 2021, then fell by 4.45% to $1.5 billion in 2022, then dropped by 8.86% to $1.3 billion in 2023, then fell by 16.35% to $1.1 billion in 2024.
  • The last three reported values for Non-Current Debt were $1.1 billion (Q1 2024), $1.3 billion (Q1 2023), and $1.5 billion (Q1 2022) per Business Quant data.